Vaping
73
13
17
43
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Published Results
19 trials with published results (26%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
2.7%
2 terminated out of 73 trials
95.6%
+9.0% vs benchmark
5%
4 trials in Phase 3/4
44%
19 of 43 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 43 completed trials
Clinical Trials (73)
Pharmacokinetics and Pharmacodynamics of Synthetic Nicotine and Nicotine Analogues
Varenicline and Accelerated Transcranial Magnetic Stimulation (TMS) for Quitting Nicotine Use (Pilot Study)
Vape Use Among Younger & Older Smokers
Vaping Cessation Using the Ottawa Model for Smoking Cessation Among E-Cigarette Users
Evaluating Narrative Vaping Prevention Video Ads for Adolescents and Young Adults
Network Intervention to Prevent Vaping
Concentration Impact Nicotine Salt
Social Media Anti-Vaping Messages to Reduce ENDS Use Among Sexual and Gender Minority Teens
E-cigarette Social Media Marketing and Its Perceptions by Youth
Social Media Support Groups for Adolescent Vaping Cessation
Behavioral Intervention for Youth to Promote Vaping Cessation
Perceived Effectiveness of Vaping Prevention Ads Among Adolescents and Young Adults
Implementing an Adolescent and Young Adult (AYA) mHealth Vaping Cessation Program Into Oncology Clinics
Nicotine and Cannabis Vape Labeling Experiment - Spring 2025
Early Detection of Vaping-related Vascular Diseases
Testing a School-Based E-cigarette, Tobacco, and Betel (Areca) Nut Use Prevention Curriculum for Guam Youths
TUBSIS 2.0 - Tobacco Use Behavioral Support and Intervention System
Cessation of Smoking Trial in the Emergency Department
Secondhand Effects of Hookah (i.e., Waterpipe) Smoke and Aerosol
The Canadian Lung Outcomes in Users of Vaping Devices Study